Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.36 |
| ▸ | PRKDC | P78527 | 5/20 | 0.36 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.34 |
| ▸ | GPR3 | P46089 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.33 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21693065 | 0.90 | ALOX5 (0.54) | ALOX5PARP14SLC22A12PRKDCSLC9A1 | |
| SCHEMBL21691655 | 0.89 | ALOX5 (0.52) | ALOX5PARP14SLC22A12PRKDCSLC9A1 | |
| SCHEMBL21691736 | 0.88 | ALOX5 (0.40) | ALOX5PARP14SLC22A12PRKDCPIK3CD | |
| SCHEMBL21692487 | 0.88 | ALOX5 (0.51) | ALOX5PARP14SLC22A12PRKDCSLC9A1 | |
| SCHEMBL21691656 | 0.88 | ALOX5 (0.51) | ALOX5PARP14SLC22A12PRKDCSLC9A1 | |
| SCHEMBL21691585 | 0.88 | ALOX5 (0.51) | ALOX5PARP14SLC22A12PRKDCSLC9A1 | |
| SCHEMBL21691570 | 0.87 | ALOX5 (0.48) | ALOX5PARP14SLC22A12PRKDCSLC9A1 | |
| SCHEMBL21692332 | 0.86 | ALOX5 (0.50) | ALOX5PARP14SLC22A12PRKDCSLC9A1 | |
| SCHEMBL21691582 | 0.85 | ALOX5 (0.52) | ALOX5PARP14SLC22A12PRKDCTNKS | |
| SCHEMBL21691562 | 0.85 | ALOX5 (0.46) | ALOX5PARP14SLC22A12PRKDCSLC9A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11053228-B2 | Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-07-06 | — | — | US | disclosed |
| US-20200031812-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND | SAMSUNG SDI CO., LTD. (KR) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11053228-B2 | Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound | CCNL2, ARL1, CRY1 | ALOX5 2220/4885PARP14 1715/4885SLC22A12 3782/4885 |
| US-20200031812-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND | CCNL2, ARL1, CRY1 | ALOX5 2220/4885PARP14 1715/4885SLC22A12 3782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.